Zoetis Derm (10/5/2022)

CB Partner Webinar {{webinarsregistrationpage::webinar_title}} {{webinarsregistrationpage::race_approved}} true 1 Credit Hour {{webinarsregistrationpage::hero_image}} {{webinarsregistrationpage::hero_image_self_hosted}} {{webinarsregistrationpage::hero_image_desktop_background_position}} {{webinarsregistrationpage::hero_image_mobile_background_position}} {{webinarsregistrationpage::hero_image_custom_padding}} {{webinarsregistrationpage::hero_image_custom_padding_mobile}} Zoetis {{webinarsregistrationpage::supported_by}} {{webinarsregistrationpage::multiple_speakers}}

Allergy season is in full swing. In this webinar, Dr. Lindsay McKay will share her experience as a veterinary dermatologist and insights on challenging allergic dermatitis patients. She will share real-world cases supported by published studies and science to help answer your questions on antihistamine efficacy, how skin infections can make allergy drugs less effective, and how to improve success with allergen immunotherapy. Dr. McKay will present a refresh on Apoquel® (oclacitinib tablet)’s speed of onset, anti-inflammatory activity, and updated safety data, as well as how to maximize success with Cytopoint® injections.

{{webinarsregistrationpage::inside_the_webinar_2}} {{webinarsregistrationpage::inside_the_webinar_3}} Why skin infections are a major reason for allergy treatment failure The science and data behind why antihistamines do not work in most cases of allergic itch in dogs How to maximize success with allergy immunotherapy according to new data Explore the studies that support how Apoquel works as fast as steroids in reducing allergic itch in dogs and how Apoquel has anti-inflammatory activity, not just anti-itch effects in dogs with allergic dermatitis Become familiar with Apoquel’s 5-year safety data How some patients with an initial response to Cytopoint may benefit from additional injections {{webinarsregistrationpage::additional_subhead}}

Apoquel®-Important Safety Information

Do not use Apoquel (oclacitinib tablet) in dogs less than 12 months of age or those with serious infections. Apoquel may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post-approval. Apoquel has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. Apoquel has been used safely with many common medications including parasiticides, antibiotics and vaccines. For more information, please see the full Prescribing Information at Apoquel.com/pi.

Apoquel® Indications: Control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

Cytopoint® Indications: Cytopoint has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.

In adherence with RACE guidelines, CE certificates can only be distributed to individual registrants under the name used upon registration. Group viewers will not be eligible to receive multiple CE certificates.